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Abstract  
BACKGROUND: Gastrointestinal symptoms are a common feature in infants with congenital heart 
disease.  
AIM: This study was designed to evaluate age-dependent serum levels of antigliadin antibodies 
among malnourished Egyptian infants with congenital heart disease (CHD) and gastrointestinal 
symptoms.  
SUBJECTS AND METHODS: This case-control study conducted on 60 infants with established 
congenital heart disease. They were subdivided into cyanotic and acyanotic groups, and each 
group includes 30 patients compared with thirty apparently healthy infants of matched age, sex, and 
social class. Serum antigliadin antibodies levels were measured using ELISA.  
RESULTS: The mean age of introduction of cereals in the diet and appearance of gastrointestinal 
symptoms were six months. On comparison with controls, patients showed highly significant higher 
serum levels of antigliadin antibodies (P < 0.000). On analysing risk factors using odds ratio, the 
age at onset of GIT symptoms, diarrhoea, abdominal pain, and distension had been found to be 
significantly associated with high serum antigliadin antibodies among malnourished CHD infants 
with a prediction of 95%.  
CONCLUSION: Serum IgA, IgM, and IgG class antibodies to gliadin play a significant role in the 
pathogenesis of malnutrition in infants with CHD. Gluten containing foods should never be 
introduced before the end of the six months. 
 
 
 
Introduction 
 
 Congenital heart diseases (CHD) are 
documented in 0.8 % of all live birth infants. They are 
characterised by gross structural abnormalities of the 
heart or the great vessels that interfere with normal 
cardiac function [1]. Malnourished infants with CHD 
showed growth retardation, frequent hospitalisation, 
poor surgical outcomes and higher mortality rate [2]. 
They also showed poor food intake, malabsorption, 
increased requirements, and higher metabolic rate in 
the first year of life [3]. Retarded growth was 
accompanied by frequent diarrhoea attacks and 
infectious diseases [4]. 
 Gliadin is part of the gluten protein found in 
the grains wheat, barley, rye, and oats. It is a unique 
protein based on its structure that lends a doughy, 
elastic consistency to flours derived from these grains. 
Some children have gluten protein intolerance, which 
may be attributed to enhanced T-cell-mediated 
immune reaction in the proximal small bowel that 
damages the villi of the small intestine and leads to 
nutrients malabsorption [5]. The inflammatory 
response continues as long as patients continue to 
ingest protein [6]. The Gluten sensitivity usually 
manifests in childhood, and symptoms include failure 
to thrive, diarrhoea, and abdominal pain. Subclinical 
cases may have no overt gastrointestinal symptoms 
but suffer osteopenia, anaemia, and irritability [7, 8]. 
 Studies to date regarding the immune 
response to gluten in infants with CHD and its 
association with gluten sensitivity have been 
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inconsistent. Therefore, this study was planned to 
evaluate age-dependent serum levels of IgA, IgG, and 
IgM antigliadin antibodies among malnourished 
Egyptian infants with CHD and gastrointestinal 
symptoms and to investigate if these antibodies have 
any relation to growth, nutritional status, and 
gastrointestinal symptoms. 
 
 
Subjects and Methods 
 
 Design and Setting of the study 
 This case-control study was conducted on 60 
infants with congenital heart disease (CHD) and 
recurrent gastrointestinal symptoms (40 % girls and 
60% boys) who were attending the Nutrition Clinic of 
the Center of Excellence, National Research Center 
(NRC) for nutritional management of malnourished 
patients with CHD over a period of one year according 
to inclusion criteria. They were referred from the 
outpatient Pediatric Cardiology Clinics of the National 
Cardiac Institute, Egypt, during their regular follow up. 
The sample size was calculated to detect the mean 
differences in the scores of the factors probably 
affecting growth, nutritional status of infants with 
congenital heart disease (CHD). 
 
 Subjects 
 Congenital cardiac defects were diagnosed by 
two-dimensional echocardiography. They were 
classified into two subgroups according to the 
presence or absence of the cyanosis into two 
subgroups; thirty cyanotic patients in subgroup I, and 
thirty acyanotic patients in subgroup II compared with 
thirty apparently healthy infants of matched age, sex, 
and social class. The inclusion criteria for selection 
included malnourished infants with uncorrected 
symptomatic congenital cardiac defects and history of 
gastrointestinal symptoms. The exclusion criteria 
included infants with palliated or corrected CHD, 
confirmed or suspected genetic syndromes, 
hospitalised, and infants with asymptomatic CHD. 
Written informed consent was obtained from the 
parents of the participating infants. 
 
 Methods 
 Information on age, parental consanguinity of 
CHD, duration of illness and treatment modalities 
were collected via a questionnaire from parents. All 
the studied patients were subjected to through history 
taking, including onset of the cyanosis, hypercyanotic 
spells, tachypnea, feeding difficulty, poor weight gain, 
repeated chest infections, gastroenteritis, and 
congestive heart failure. Patients and controls were 
subjected to a complete physical examination, 
nutritional assessment, anthropometric measures, and 
laboratory investigations that were done at the 
National Research Center. 
 The anthropometric measures included 
measurement of body weight, recumbent length or 
height, body mass index (BMI), occipitofrontal, mid-
arm, and mid chest circumferences. The body weight 
was determined to the nearest 0.1 kg on a sea scale 
balance with the subject dressed minimum clothes 
and no shoes. Heights or recumbent length (for 
infants <2 years of age) were measured using Seca 
mechanical infantometer. The mid-upper arms, mid-
chest and occipitofrontal circumferences were 
measured with a measuring tape using standard 
procedures. Each measurement was taken as the 
mean of three consecutive readings as recommended 
by the International Biological program [9]. 
 The anthropometric analysis for all infants 
was accomplished through the calculation of Z-scores, 
based on the WHO growth standards [10], and Anthro 
2007© software [11]. Z-scores were calculated for the 
following rates: weight/age, weight/length, length /age. 
The following were adopted as cut-off points for the z-
values: normal values between two units of a standard 
deviation below and above the average value. In all 
cases, a Z-score of less than -2 was considered as 
the cut-off point for malnutrition. Values between ± 1 
and ± 2 SD units of standard deviation constituted the 
zone of risk. 
 
 Biochemical measurements 
 From all cases, and controls five cc venous 
blood samples were obtained for laboratory assays, 
which were performed in the National Research 
Center. Serum antigliadin IgA, IgG, and IgM 
antibodies levels were measured by enzyme-linked 
immunosorbent assay (ELISA) commercial kit 
according to the method of Trocone and Ferguson 
[12]. The cutoff value was calculated from healthy 
control samples. 
 Serum calcium concentration was assayed by 
a colorimetric method according to the method 
described by Endres and Rude [13]. Samples for 
assaying serum alkaline phosphatase activity (ALP) 
were kept at room temperature and assayed 
according to the manufacturer’s guidelines [14]. 
Haemoglobin level was measured using Hemoglobin 
Photometer [15]. Serum iron and total iron binding 
capacity were measured according to the method 
described by Perrotta and Kaplan [16]. 
 
 Statistical analysis 
 Statistical analysis was performed using the 
SPSS statistical package software for Windows 
version 21 (SSPS Inc, Chicago, USA) and the results 
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were presented as tables and figures. Quantitative 
variables are expressed as the mean ± SD. 
 Categorical data were expressed as 
frequencies and percentages and were analysed with 
the two-tailed chi-square test. Correlations between 
continuous variables were done using Pearson 
correlation. The comparison between groups was 
performed with one-way analysis of variance 
(ANOVA). Univariate analysis of each covariate (item 
by item) was performed to identify significant of high 
serum levels of antigliadin antibodies in malnourished 
patients with CHD and gastrointestinal symptoms. A P 
value < 0.05 was considered significant and p < 0.005 
was considered highly significant. 
 
 
Results 
 
 This study comprised 60 patients with 
established CHD. Their ages ranged from 4-12 
months (mean 8.72 ± 6.68 months) were enrolled in 
the present study. They were 36 boys (60 %) and 24 
girls (40%) with a male to female ratio 1.5:1. Cyanosis 
was detected in 30 patients (50%). About 60% of the 
studied patients were on bottle feeding, and 40% 
patients were breastfed. 
 Cereals were introduced at a mean age of 6 
months (ranging from 4 to 8 months), and the mean 
age of onset of gastrointestinal symptoms was six 
months. Such symptoms entailed chronic diarrhoea in 
58 (96.7%), vomiting in 26 (43.3%), abdominal pain in 
38 (63.3%), and abdominal distension in 14 (23.3%). 
Growth failure was seen in 48 patients (80%), pallor in 
44 patients (73.3%), and rickets in 34 patients 
(56.7%). Thirty patients (50%) received anti-failure 
medications. All these clinical findings concerning the 
patient's group are shown in Table 1. 
Table 1: Clinical findings of the studied patients 
Variables No (%) Variables No (%) 
Male 
Female 
26 (43.3%) 
34 (56.7%) 
Pallor 44 (73.3%) 
Positive consanguinity 24 (40 %) Rickets 34 (56.7%) 
Diarrhea 58 (96.7%) 
Repeated chest 
infections 
12 (20%) 
Vomiting 26 (43.3%) 
Anti-heart failure 
medications 
30 (50%) 
Abdominal pain 38 (63.3%) 
Abdominal 
distension 
14 (23.3%) 
 
 The mean measurements of z scores of 
weight for age, weight for height, height for age, and 
the circumferences of occipitofrontal, mid arm, and 
mid chest of the studied patients were statistically 
highly significant lower compared to controls (P < 
0.001). The mean weight for age, weight for height Z-
scores, circumferences of occipitofrontal, mid arm of 
the cyanotic group were statistically significant lower 
about the acyanotic group (P < 0.05). Table 2 
demonstrates the anthropometric measures of 
patients versus control. 
Table 2: Comparison of anthropometric measures of the 
studied patients, and control groups 
 
Variables 
Total 
Patients 
N=60 
Cyanotic 
subgpI 
n=30 
Acyanotic 
subgpII 
n=30 
Control 
Group 
N=30 
subgpI 
versus 
subgpII 
Total 
patients 
versus 
controls 
Mean ±SD Mean ±SD Mean ±SD Mean ±SD P value P value 
Occipitofrontal 
circumference(cm) 
 
42.93±3.59 
 
41.53±3.86 
 
44.33±2.76 
 
46.4±3.55 
 
0.03* 
 
0.002** 
Mid-arm 
circumference(cm) 
12.2±1.66 11.43±1.69 12.97±1.27 13.49±0.9 0.002** 0.003** 
Mid-chest 
circumference(cm) 
44.0±4.38 43.27±5.2 44.73±3.42 49.85±3.31 0.32 0.000** 
Weight for age z-
score 
-2.55±1.27 -3.18±0.9 -2.02±1.29 -0.25±0.42 0.003** 0.000** 
Height for age z-score -2.62±1.4 -3.07±1.28 -2.38±1.35 0.25±0.55 0.107 0.000** 
Wt for Ht z score -0.75±1.0 -1.34±0.88 -0.28±1.07 -0.24±0.65 0.001** 0.03* 
*Significant difference at p<0.05, **highly significant difference at p<0.005. 
  
 The patients' group demonstrated a 
statistically highly significant increase in serum levels 
of IgA, IgM, and IgG class antibodies to gliadin on 
healthy controls (P < 0.000). ANOVA test revealed 
statistically highly significant rise in the serum levels of 
IgA, IgM, and IgG class antibodies to gliadin, alkaline 
phosphatase activity, total iron binding capacity, and 
statistically highly significant reduction in blood 
hemoglobin, serum calcium and iron levels between 
the patients' subgroups and controls with the lowest 
value in the cyanotic group (P < 0.001) as shown in 
Table 3. 
Table 3: Comparison of laboratory findings of the studied 
patients, and control groups 
Variables 
Cyanotic 
subgroup I 
n=30 
Acyanotic 
subgroup II 
n=30 
Control 
Group 
N=30 
ANOVA 
Mean ±SD Mean ±SD Mean ±SD F P 
Serum antigliadin 
IgA (IU/ml) 
151.95±59.4 150.81±27.84 92.07±2.67 104.17 0.000** 
Serum antigliadin 
IgG (IU/ml) 
111.95±109.83 142.16±138.57 70.77±17.51 1.4 0.251 
Serum antigliadin 
IgM (IU/ml) 
3.9±2.63 2.8±1.52 1.1± 0.33 431.96 0.00** 
Serum calcium 
(mg/dl) 
8.35±0.23 8.46± 0.52 9.38±0.29 31.35 0.00** 
Serum alkaline 
phosphatase 
(IU/l) 
336.53±84.1 380.71±110.56 106.4±14.38 66.702 0.00** 
HB (gm/dl) 13.78 ± 1.8 11.54 ± 1.7 13.05 ± 0.77 5.495 0.007** 
Serum iron (mcg/dl) 40.56±8.03 33.40±6.10 73.5±8.75 138.22 0.00** 
Serum TIBC (mcg/dl) 432.0±14.52 388.53±37.44 285.4±27.4 109.28 0.00** 
*Significant difference at p<0.05, **highly significant difference at p<0.005. 
 
 In the patient's group, serum IgM levels 
showed significantly negative correlation with serum 
calcium levels, and height for age z- score (P < 0.05). 
Serum antigliadin IgG levels were significantly 
positively correlated with serum alkaline phosphatase 
activity, and negatively correlated with z- score of 
weight for age. Correlations between anthropometric 
measures and serum antigliadin antibodies of the 
studied patients are shown in Table 4. 
Table 4: Correlations between weight and height for age z-
score, some laboratory measures and serum antigliadin 
antibodies of the studied patients
 
Variables 
Weight/age z-
score 
Height / 
age z-score 
Serum  
calcium 
Serum alkaline 
phosphatase 
Serum antigliadin IgM 
(IU/ml) 
-0.107 -0.265* -0.331* 0.117 
Serum antigliadin IgG 
(IU/ml) 
-0.261* 0.111 0.189 0.292* 
Serum antigliadin IgA 
(IU/ml) 
0.105 0.162 0.031 0.036 
*Significant difference at p<0.05, **highly significant difference at p<0.005. 
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Table 5: Univariate analysis between GIT symptoms and serum 
antigliadin IgA antibodies levels in the studied patients 
 Covariates 
Serum  antigliadin antibodies (IgA) 
High 
26 (60%) 
Normal 
34 (40%) 
P 
value 
Odd ratio (95% 
CI) 
No % No % 
Age at onset of 
symptoms 
Before 6 
month 
8 (30.8%) 22 (64.7%) 0.04* 4.13 (0.88,19.27) 
Diarrhea Negative 4 (15.4%) 26 (76.5%) 0.02*  0.06  (0.01, 0.37) 
Abdominal pain  Positive 20 (76.9%) 22 (64.7%) 0.01* 0.55  (0.11, 2.80) 
Abdominal distension Positive 20 (76.9%) 10 (29.4%) 0.01* 0.13  (0.02, 0.66) 
*Significant difference at p < 0.05, **highly significant difference at p < 0.005. 
Gastrointestinal symptoms (GIT). 
 
 On analysing risk factors using odds ratio, the 
age at onset of gastrointestinal symptoms in the form 
of diarrhoea, abdominal pain and distension were 
documented as a significant association of raised 
serum levels of antigliadin antibodies in the patients 
with a prediction of 95% as shown in Tables 5, 6, 7. 
Table 6: Univariate analysis between GIT symptoms and serum 
antigliadin IgG antibodies levels in the studied patients 
 
                        Covariates 
           Serum  antigliadin antibodies (IgG) 
High 
12 (20%) 
Normal 
48 (80%) P value 
 
Odd ratio (95% 
CI) No % No % 
Age at onset of 
symptoms 
Before 6 
month 
16 (38.1%) 14 (77.8%) 0.04* 5.69  (0.94, 34.46) 
Diarrhea Negative 0 (0%) 30 (62.5%) 0.02* 0.06  (0.01, 0.37) 
Abdominal pain  Positive 10 (83.3%) 32 (66.7%) 0.01* 0.55  (0.11, 2.80) 
Abdominal 
distension  
Positive 12 (100%) 18 (37.5%) 0.01* 0.13  (0.02, 0.66) 
*Significant difference at p < 0.05, **highly significant difference at p < 0.005. 
Gastrointestinal symptoms (GIT). 
 
 
 
Discussion 
 
 The poor growth seen in infants born with 
complex heart defects may result from factors beyond 
deficient nutrition [17]. The cause is not yet identified. 
However, it may be a consequence of a disordered 
immune response to gliadin proteins in genetically 
predisposed infants or may be attributed to the early 
introduction of cereals in the infant's diet before the 
age of 6 months, yielding higher levels of antibodies 
against such proteins [6]. There are three types of 
antigliadin antibodies, IgA, IgM, and IgG. IgA antibody 
is specific, and the IgG antibody is a sensitive marker 
of gluten sensitivity.
 
Table 7: Univariate analysis between GIT symptoms and serum 
antigliadin IgM antibodies levels in the studied patients 
Covariates 
Serum antigliadin antibodies ( IgM) 
High 
42 (70%) 
Normal 
18 (30%)    P 
value 
     
Odd ratio 
(95% CI) 
 
No % No % 
Age at onset of 
symptoms 
Before 6 
month 
20 (38.1%) 14 (77.8%) 0.04* 5.69     (0.49, 4.46) 
Diarrhea  Negative 20 (47.6%) 10 (55.6%) 0.60 0.73      (0.15, 3.49) 
Abdominal pain  Positive 10 (83.3%) 2 (11.1%) 0.00** 0.01     (0.00, 0.11) 
Abdominal 
distension  
Positive 26 (61.9%) 4 (22.2%) 0.04* 0.18     (0.03, 1.07) 
 
 Measurement of the combined antibodies 
provides a specificity of 84% and a sensitivity of 94% 
for the diagnosis of gluten sensitivity disease [18]. 
 Up till now, there is no available information in 
the literature regarding the presence of serum 
antigliadin antibodies among malnourished infants 
with congenital heart diseases. 
 Our study comprised sixty patients suffering 
from CHD. They were diagnosed by clinical 
examination, echocardiography, and other routine 
tests. Such patients were further subdivided into 
acyanotic and cyanotic subgroups. The commonest 
cyanotic lesions were tetralogy of Fallot (TOF) and 
transposition of the great arteries (20% in each). 
Almost 5 % of our patients suffered from pulmonary 
atresia with ventricular septal defect (VSD), and 5 % 
presented with double outlet right ventricle (DORV) 
with malposed great vessels. 
 Ventricular septal defect (VSD) was the most 
frequent acyanotic lesions (20%), 15% of our patients 
were diagnosed as patent ductus arteriosus (PDA), 
10% as atrial septal defect (ASD), and 5% as an 
atrioventricular canal (A-V canal).
 
 About 60% of our patients were on mixed 
feeding, and 40% patients were breastfed. Cereals 
were introduced at a mean age of 6 months (ranging 
from 4 to 8 months) and mean age of onset of 
gastrointestinal symptoms was six months. Such 
symptoms included chronic diarrhoea in (96.7%), 
vomiting in (43.3%), abdominal pain in (63.3%), and 
abdominal distension in (23.3%). Growth failure was 
seen in (70%), pallor in (73.3%), and rickets in 
(56.7%) of patients. The earlier onset of 
gastrointestinal symptoms in our studied patients was 
not in agreement with Assiri et al., [19] who found that, 
gastrointestinal symptoms started at a mean age of 
57.2 months (ranging from 4 to 156 months) and 
manifested in 54% as chronic diarrhea, in 22.2% as 
vomiting, in 17.5% as abdominal pain, and in 3.2% 
patients as abdominal distension. Growth failure was 
detected in 74.6% patients. The early introduction of 
cereals in our patients may be responsible for the 
early appearance of gastrointestinal symptoms. 
 In view of our data, the mean measurements 
of z-scores of weight for age and height for age, 
weight for height, as well as the circumferences of 
occipitofrontal, mid arm, and mid chest of the patients 
group showed statistically highly significantly 
decrease when compared to controls (P < 0.001), and 
statistically significantly lower in cyanotic group than 
acyanotic group (P < 0.05). Severe malnutrition was 
found in thirty-three (55%) of the studied patients, 
while moderate malnutrition was shown in twenty-
seven (45%). Thirty-six (60%) of our patients 
manifested a decreased WHZ (wasting), which was 
proportionately more documented in the cyanotic 
group (P < 0.001). Our results are in agreement with 
WHO reports, which demonstrated that malnutrition 
manifests mainly as wasting rather than underweight 
and stunting [20]. 
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 Studies concerning malnutrition patterns 
amongst patients with CHD yielded incontinent results 
(21-23). In South India, Vaidyanathan et al., [21] 
recorded underweight in (59.0%) with wasting being 
more evident than stunting in infants suffering from 
CHD. These results came from our data. El-Alameey 
et al., [22], and Varen et al., [23], stated that wasting 
was more common in cyanotic CHD than in acyanotic 
CHD. 
 Anaemia is an important risk factor for 
morbidity and mortality among infants suffering from 
CHD (cyanotic and acyanotic) in the absence of 
vitamin or mineral deficiency, or hemolytic causes 
[24]. More than 30% of the patients with CHD had iron 
deficiency anaemia [25]. It may co-exist and worsen 
acyanotic CHD heart failure [26]. 
 Iron deficiency anaemia was evidenced in 
73.3 % of our patients with a statistically highly 
significant increase in serum levels of total iron 
binding capacity compared to control group (P < 
0.000). 
 By our study, Assiri et al. [19] found. Also, 
rickets was present in 6 patients (10%), it may be 
secondary to calcium deficiency, or intestinal 
malabsorption. 
 Our patients demonstrated statistically highly 
significant increased serum alkaline phosphatase 
activity and decreased serum levels of calcium than 
the control group (P < 0.000). 
 Gluten sensitivity leads to raised serum level 
of anti-gliadin IgA and IgG antibodies. Antigliadin IgA 
antibodies are more specific markers for disease than 
antigliadin IgG antibodies serving for initial screening, 
assessing diseases activity, and judging management 
with a gluten-free diet [6]. 
 To our knowledge, the present study is the 
first to document raised serum levels of antigliadin 
antibodies in malnourished infants with CHD and 
gastrointestinal symptoms. Forty-two patients with 
CHD had statistically significant higher levels of IgM 
antibody to gliadin, twenty-six patients exhibited a 
significant elevation of the serum levels of IgA anti-
gliadin antibodies and twelve patients demonstrated 
significantly increased serum levels of IgG antigliadin 
antibodies compared to control group (P < 0.000). A 
statistically highly significant elevation of the serum 
levels of IgA, IgM, and IgG antigliadin antibodies was 
evidenced in our studied patients compared to control 
group (P < 0.000). On analysing risk factors using 
odds ratio, the age at onset of gastrointestinal 
symptoms in the form of diarrhoea, abdominal pain 
and distension were documented as a significant 
strong association of raised serum levels of antigliadin 
antibodies in the infants with CHD with a prediction of 
95%. 
 In our patients, serum antigliadin IgM levels 
were significantly negatively correlated with serum 
calcium levels and height for age z- score (P < 0.05). 
Serum antigliadin IgG levels were significantly 
positively correlated with serum alkaline phosphatase 
activity, and negatively correlated with z- score of 
weight for age. These data indicated that when serum 
levels of antigliadin IgM, and IgG increased, more 
stunting and underweight was found. 
 Interestingly, our study showed clinical 
improvement of some patients on the exclusion of 
gluten from the diet and continuing of breastfeeding. 
Rapid recovery was reported concerning weight gain. 
Breastfeeding protects against repeated episodes of 
acute gastroenteritis which have been linked to 
increased risk of gluten sensitivity. This reduction 
could be mediated via immunoglobulins present in 
human milk [27, 28]. 
 From the current findings, it could be 
concluded that serum IgA, IgM, and IgG class 
antibodies to gliadin play a significant role in the 
pathogenesis of malnutrition. 
 Breastfeeding is protective, may be beneficial 
in delaying or preventing gluten sensitivity. Babies 
born with CHD must be breastfed for at least one ear. 
Gluten containing foods should be avoided for the first 
8th months of life. 
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